TINIDAZOLE 500 mg TABLETS 1. COMPOSITIONEach film-coated tablet contains: 2. PHARMACEUTICAL FORMFilm-Coated Tablet. 3. THERAPEUTIC CLASSNitroimidazole Antimicrobial / Antiprotozoal Agent. 4. INDICATIONSTinidazole is indicated for the treatment of susceptible infections, including: 5. CONTRAINDICATIONSHypersensitivity to Tinidazole, other nitroimidazole derivatives, or any component of the formulation. Blood dyscrasias or history of significant blood disorders unless specifically advised by a physician. Organic neurological disorders. Pregnancy, particularly during the first trimester, unless specifically prescribed. Breastfeeding during treatment and for the recommended period after treatment should be avoided as advised by a physician.
6. DRUG INTERACTIONSTinidazole may interact with: Alcohol: Avoid alcohol and products containing alcohol during treatment and for at least 72 hours after the last dose. Warfarin and other oral anticoagulants — may increase anticoagulant effects. Lithium — may increase lithium concentrations. Phenytoin and other enzyme-inducing medicines may affect tinidazole concentrations. Cyclosporine or tacrolimus — monitoring may be required.
7. ADMINISTRATIONTake orally with food and sufficient water, or as directed by a physician. The dosage and duration depend on the type and severity of infection. Complete the prescribed course of treatment. Do not consume alcoholic beverages during treatment and for at least 72 hours after the last dose. Do not discontinue treatment prematurely unless advised by a physician.
8. STORAGEStore below 25°C, protected from moisture, heat and direct sunlight. Keep the tablets in the original package. Keep out of reach of children. Do not use after the expiry date.
Market : international export Private Label : Available Registration Support : Available Regulatory documents : Available on request |